Genetic determinants of glycated hemoglobin levels in the Greenlandic Inuit population

European Journal of Human Genetics : EJHG
Emil V R AppelNiels Grarup

Abstract

We previously showed that a common genetic variant leads to a remarkably increased risk of type 2 diabetes (T2D) in the small and historically isolated Greenlandic population. Motivated by this, we aimed at discovering novel genetic determinants for glycated hemoglobin (HbA1C) and at estimating the effect of known HbA1C-associated loci in the Greenlandic population. We analyzed genotype data from 4049 Greenlanders generated using the Illumina Cardio-Metabochip. We performed the discovery association analysis by an additive linear mixed model. To estimate the effect of known HbA1C-associated loci, we modeled the effect in the European and Inuit ancestry proportions of the Greenlandic genome (EAPGG and IAPGG, respectively). After correcting for multiple testing, we found no novel significant associations. When we investigated loci known to associate with HbA1C levels, we found that the lead variant in the GCK locus associated significantly with HbA1C levels in the IAPGG ([Formula: see text]). Furthermore, for 10 of 15 known HbA1C loci, the effects in IAPGG were similar to the previously reported effects. Interestingly, the ANK1 locus showed a statistically significant ancestral population differential effect, with opposing direct...Continue Reading

References

Nov 1, 1984·The American Journal of Medicine·M A ShippG P Canellos
Feb 10, 2000·Clinical Biochemistry·D ChevenneF Trivin
Mar 28, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Jan-Olof JeppssonUNKNOWN International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Sep 28, 2002·Diabetes Care·Marit E JørgensenKnut Borch-Johnsen
Dec 10, 2003·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Torben JørgensenCharlotta Pisinger
Apr 27, 2007·Nature Genetics·Valgerdur SteinthorsdottirKari Stefansson
Jun 23, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kristina Jackson BehanHong-Kee Lee
Aug 4, 2009·Genome Research·David H AlexanderKenneth Lange
Mar 5, 2010·The New England Journal of Medicine·Elizabeth SelvinFrederick L Brancati
Aug 27, 2010·The Journal of Clinical Endocrinology and Metabolism·Marit Eika JørgensenDaniel Witte
Dec 3, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M E JørgensenP Bjerregaard
Jun 19, 2012·Nature Genetics·Xiang Zhou, Matthew Stephens
May 10, 2013·Diabetes Care·Marit Eika JørgensenPeter Bjerregaard
Dec 9, 2014·The Journal of Clinical Investigation·Syed HussainJames Gardiner
Jan 6, 2015·American Journal of Human Genetics·Ida MoltkeAnders Albrechtsen
Sep 19, 2015·Science·Matteo FumagalliRasmus Nielsen
Apr 26, 2016·The Review of Diabetic Studies : RDS·Niels GrarupTorben Hansen
Jun 30, 2016·Nature Communications·Laura J ScottStephen C J Parker
Dec 6, 2018·BioRxiv : the Preprint Server for Biology·Line SkotteA. Albrechtsen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
chip

Software Mentioned

MetaboChip
asaMAP
Illumina GenomeStudio
ADMIXTURE
GEMMA

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.